Unique ID issued by UMIN | UMIN000007710 |
---|---|
Receipt number | R000009090 |
Scientific Title | Prospective study about immunization of attenuated live vaccines in children receiving immunosuppressants |
Date of disclosure of the study information | 2012/04/13 |
Last modified on | 2018/04/15 10:07:42 |
Prospective study about immunization of attenuated live vaccines in children receiving immunosuppressants
Study about live vaccines in children receiving immunosuppressants
Prospective study about immunization of attenuated live vaccines in children receiving immunosuppressants
Study about live vaccines in children receiving immunosuppressants
Japan |
Patients under treatment of immunosuppressants (CsA, FK, MZR, NNF, AZP)
Gastroenterology | Nephrology | Infectious disease |
Pediatrics | Child |
Others
NO
Examination of the efficacy and safety of immunization with attenuated live vaccines in patients receiving immunosuppressants.
Safety,Efficacy
1) Analysis of antibody acquisition after vaccination classified by each virus.
2) Analysis of maintenance of acquired immunity classified by each virus especially after 1 year.
3) Analysis of incididence of adverse events classified by each virus.
1) Analysis of causes of vaccine failure.
2) Analysis of causes of adverse events.
3) Analysis of effect for prevention of virus infection.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Live attenuated vaccine
1 | years-old | <= |
Not applicable |
Male and Female
1.Equal or more than one years old.
2. Patients under treatment of immunosuppressants (CsA, FK, MZR, MMF, AZP, MTX)
3. Negative or borderline antibody titer of one or more of the following viruses: measles, rubella, varicella, or mumps.
4. Patients who cannot discontinue immunosuppressants because of primary disease.
5. Inactive primary disease.
6. Normal cellular immunity (CD4 counts>500/mm3, PHA lymphocyte stimulatory test-stimulation index>101.6).
7. Serum IgG level>300mg/dl
8. FK trough level<10ng/ml or CsA trough level<100ng/ml.
9. Approved by the committee for attenuated live vaccination in children receiving immunosuppressants.
1. Steroid use of more than 1mg/kg/d.
2. For renal transplant recipients, <1 year since transplantation or acute rejection within the previous 6 months.
200
1st name | |
Middle name | |
Last name | Koichi Kamei |
National Center for Child Health and Development
Nephrology and Rheumatology
2-10-1, Okura, Setagaya-ku, Tokyo
+81-3-5494-7128
kamei-k@ncchd.go.jp
1st name | |
Middle name | |
Last name | Koichi Kamei |
National Center for Child Health and Development
Nephrology and Rheumatology
2-10-1, Okura, Setagaya-ku, Tokyo
+81-3-5494-7128
kamei-k@ncchd.go.jp
Department of Nephrology and Rheumatology
National Center for Child Health and Development
none
Other
NO
2012 | Year | 04 | Month | 13 | Day |
Partially published
Completed
2012 | Year | 04 | Month | 09 | Day |
2012 | Year | 05 | Month | 01 | Day |
2018 | Year | 03 | Month | 31 | Day |
2018 | Year | 03 | Month | 31 | Day |
2018 | Year | 03 | Month | 31 | Day |
2018 | Year | 04 | Month | 30 | Day |
2012 | Year | 04 | Month | 10 | Day |
2018 | Year | 04 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009090
Research Plan | |
---|---|
Registered date | File name |
2017/10/14 | 研究計画書20161122.doc |
Research case data specifications | |
---|---|
Registered date | File name |
2017/10/14 | 接種回数 n=169 201105-201701.xlsx |
Research case data | |
---|---|
Registered date | File name |
2017/10/14 | 接種回数 n=169 201105-201701.xlsx |
Value
https://center6.umin.ac.jp/ice/9090